Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,087 across all filing types
Latest filing 2023-07-13 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics PLC
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities of an offeror/offeree (Horizon Therapeutics PLC) by a major shareholder (Citadel Group). This type of disclosure is a regulatory requirement for transparency during takeover activities and does not fit into specific categories like M&A announcements (which are usually from the companies themselves) or director dealings. Therefore, it is classified as a Regulatory Filing (RNS).
2023-07-13 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of 'NETWORK INTERNATIONAL HOLDINGS PLC'. Since this is a specific regulatory disclosure regarding shareholdings and dealings in the context of a takeover, and does not fit into the other specific categories like 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'Director's Dealing', it is best classified as a Regulatory Filing (RNS).
2023-07-13 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in securities during an M&A process. Since it is a specific regulatory disclosure form related to takeover activity and does not fit into the other categories like M&A announcements (TAR) or general regulatory filings (RNS) as perfectly as it fits the regulatory disclosure requirement, it is classified as a Regulatory Filing (RNS).
2023-07-12 English
Form 8.3 - Horizon Therapeutics PLC
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details an 'Opening Position Disclosure/Dealing Disclosure' by Citadel Group regarding their interests and dealings in the securities of Horizon Therapeutics PLC. This type of filing is a specific regulatory requirement for major shareholders or parties involved in takeover situations to disclose their positions and transactions. It does not fit into categories like Annual Reports, Earnings Releases, or Director's Dealings, and is best classified as a Regulatory Filing (RNS) as it is a formal disclosure to a regulatory body.
2023-07-12 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of filing is a standard regulatory requirement for major shareholders during M&A activity and is classified as a Major Shareholding Notification (MRQ) as it pertains to the disclosure of significant share ownership levels and related derivative positions.
2023-07-11 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of 'Network International Holdings PLC' by 'Citadel Group'. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, and it does not fit into the other specific categories like 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'Director's Dealing', it is best classified as a Regulatory Filing (RNS).
2023-07-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.